| Hemoglobin (3 month average), categories |
| <9.0 g/dl | 9.0-9.9 g/dl | 10.0-10.9 g/dl | 11.0-11.9 g/dl | 12.0-12.9 g/dl | 13.0+ g/dl | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total N | N | Weighted % | N | Weighted % | N | Weighted % | N | Weighted % | N | Weighted % | N | Weighted % | ||
| National sample | Month | |||||||||||||
| Overall | AUG10 | 3,099 | 28 | 0.8% | 125 | 3.5% | 606 | 19.0% | 1,501 | 49.8% | 694 | 22.5% | 145 | 4.5% |
| SEP10 | 3,154 | 41 | 1.1% | 117 | 3.5% | 570 | 17.4% | 1,631 | 53.6% | 664 | 20.4% | 131 | 4.0% | |
| OCT10 | 3,216 | 40 | 1.4% | 113 | 3.2% | 629 | 18.8% | 1,616 | 49.7% | 682 | 22.7% | 136 | 4.2% | |
| NOV10 | 3,243 | 38 | 1.0% | 97 | 3.2% | 663 | 19.4% | 1,653 | 49.7% | 663 | 22.4% | 129 | 4.4% | |
| DEC10 | 3,459 | 31 | 0.7% | 141 | 4.3% | 679 | 18.8% | 1,802 | 51.8% | 664 | 20.0% | 142 | 4.3% | |
| JAN11 | 3,419 | 30 | 0.9% | 136 | 4.2% | 732 | 20.9% | 1,776 | 52.5% | 609 | 17.4% | 136 | 4.1% | |
| FEB11 | 3,403 | 32 | 0.9% | 148 | 4.5% | 747 | 22.1% | 1,752 | 52.0% | 599 | 16.4% | 125 | 4.1% | |
| MAR11 | 3,439 | 43 | 1.2% | 162 | 4.9% | 758 | 22.7% | 1,799 | 51.9% | 531 | 14.7% | 146 | 4.7% | |
| APR11 | 3,590 | 39 | 1.1% | 170 | 4.9% | 798 | 22.4% | 1,880 | 52.4% | 561 | 15.1% | 142 | 4.1% | |
| MAY11 | 3,609 | 34 | 1.0% | 150 | 4.4% | 798 | 22.6% | 1,893 | 51.8% | 584 | 15.9% | 150 | 4.3% | |
| JUN11 | 3,616 | 41 | 1.3% | 137 | 4.4% | 787 | 21.7% | 1,936 | 52.8% | 557 | 15.2% | 158 | 4.7% | |
| JUL11 | 3,617 | 41 | 1.6% | 143 | 4.6% | 788 | 20.9% | 1,939 | 52.2% | 542 | 15.8% | 164 | 4.8% | |
| AUG11 | 3,717 | 46 | 1.5% | 155 | 4.2% | 879 | 24.1% | 1,939 | 52.0% | 541 | 13.9% | 157 | 4.4% | |
| SEP11 | 3,722 | 44 | 1.3% | 159 | 4.4% | 1,024 | 32.5% | 1,862 | 45.4% | 467 | 12.0% | 166 | 4.3% | |
| OCT11 | 3,668 | 51 | 1.6% | 204 | 7.5% | 1,093 | 34.9% | 1,728 | 40.4% | 449 | 11.8% | 143 | 3.8% | |
| NOV11 | 3,588 | 56 | 1.9% | 258 | 10.2% | 1,134 | 36.5% | 1,592 | 36.8% | 414 | 10.8% | 134 | 3.7% | |
| DEC11 | 3,509 | 63 | 2.8% | 270 | 10.7% | 1,157 | 37.9% | 1,495 | 35.4% | 383 | 9.3% | 141 | 4.0% | |
| JAN12 | 3,174 | 52 | 2.1% | 242 | 10.9% | 1,067 | 38.4% | 1,347 | 35.7% | 354 | 9.8% | 112 | 3.1% | |
| FEB12 | 3,137 | 47 | 2.3% | 265 | 10.5% | 1,082 | 39.0% | 1,323 | 36.3% | 315 | 9.1% | 105 | 2.8% | |
| MAR12 | 1,613 | 26 | 2.2% | 144 | 12.9% | 601 | 39.9% | 639 | 33.0% | 150 | 8.1% | 53 | 3.9% | |
| APR12 | 6,960 | 218 | 2.4% | 885 | 12.2% | 2,570 | 43.9% | 2,364 | 31.2% | 684 | 7.3% | 239 | 3.1% | |
| MAY12 | 8,049 | 196 | 2.4% | 949 | 10.9% | 3,225 | 45.5% | 2,744 | 31.4% | 673 | 6.7% | 262 | 3.1% | |
| JUN12 | 8,432 | 224 | 2.2% | 1,006 | 11.5% | 3,418 | 45.2% | 2,841 | 32.0% | 671 | 6.2% | 272 | 2.8% | |
| JUL12 | 8,799 | 250 | 1.8% | 1,090 | 11.9% | 3,562 | 45.8% | 2,938 | 31.9% | 675 | 5.6% | 284 | 3.0% | |
| AUG12 | 9,364 | 273 | 2.4% | 1,170 | 11.0% | 3,835 | 45.0% | 3,063 | 31.9% | 707 | 6.2% | 316 | 3.5% | |
| SEP12 | 9,571 | 279 | 2.7% | 1,149 | 9.0% | 3,935 | 46.5% | 3,184 | 32.2% | 708 | 6.6% | 316 | 3.0% | |
| OCT12 | 9,632 | 277 | 2.9% | 1,146 | 9.8% | 4,059 | 45.8% | 3,125 | 31.5% | 710 | 6.9% | 315 | 3.0% | |
| NOV12 | 9,790 | 273 | 2.1% | 1,184 | 9.9% | 4,166 | 45.2% | 3,172 | 32.6% | 680 | 7.0% | 315 | 3.2% | |
| DEC12 | 9,848 | 281 | 1.5% | 1,243 | 11.5% | 4,189 | 44.8% | 3,152 | 32.0% | 677 | 7.2% | 306 | 3.1% | |
| JAN13 | 9,819 | 282 | 2.1% | 1,251 | 10.9% | 4,207 | 44.8% | 3,116 | 32.6% | 660 | 6.3% | 303 | 3.3% | |
| FEB13 | 9,877 | 304 | 2.2% | 1,356 | 13.5% | 4,272 | 45.7% | 2,986 | 29.9% | 639 | 5.7% | 320 | 3.1% | |
| MAR13 | 9,946 | 321 | 2.7% | 1,430 | 13.8% | 4,312 | 45.1% | 2,922 | 29.6% | 643 | 5.4% | 318 | 3.5% | |
| APR13 | 9,937 | 312 | 2.7% | 1,434 | 13.5% | 4,413 | 44.1% | 2,818 | 30.9% | 647 | 5.6% | 313 | 3.1% | |
| MAY13 | 9,849 | 341 | 2.2% | 1,379 | 10.8% | 4,373 | 47.2% | 2,825 | 31.4% | 624 | 5.6% | 307 | 2.8% | |
| JUN13 | 9,965 | 312 | 2.2% | 1,461 | 10.6% | 4,446 | 48.9% | 2,828 | 29.7% | 592 | 5.3% | 326 | 3.4% | |
| JUL13 | 9,931 | 337 | 1.9% | 1,384 | 12.1% | 4,436 | 45.6% | 2,848 | 31.4% | 608 | 5.7% | 318 | 3.2% | |
| AUG13 | 9,884 | 309 | 2.4% | 1,384 | 11.4% | 4,468 | 47.6% | 2,784 | 29.6% | 640 | 5.9% | 299 | 3.1% | |
| SEP13 | 9,788 | 290 | 2.4% | 1,297 | 10.3% | 4,554 | 50.8% | 2,691 | 26.6% | 646 | 6.7% | 310 | 3.2% | |
| OCT13 | 9,685 | 295 | 2.2% | 1,370 | 9.9% | 4,428 | 51.8% | 2,658 | 26.7% | 611 | 6.3% | 323 | 3.2% | |
| NOV13 | 9,710 | 335 | 2.0% | 1,421 | 12.6% | 4,330 | 48.4% | 2,696 | 27.4% | 616 | 6.7% | 312 | 2.9% | |
| DEC13 | 9,666 | 329 | 2.6% | 1,453 | 12.7% | 4,300 | 48.6% | 2,656 | 26.0% | 601 | 7.0% | 327 | 3.1% | |
| JAN14 | 9,541 | 299 | 2.3% | 1,425 | 12.3% | 4,296 | 50.1% | 2,591 | 25.7% | 616 | 6.5% | 314 | 3.0% | |
| FEB14 | 9,456 | 310 | 3.5% | 1,418 | 12.9% | 4,255 | 49.6% | 2,567 | 24.9% | 590 | 6.0% | 316 | 3.2% | |
| MAR14 | 9,313 | 289 | 3.0% | 1,442 | 14.9% | 4,226 | 48.1% | 2,455 | 24.4% | 579 | 6.0% | 322 | 3.6% | |
| APR14 | 9,143 | 308 | 3.1% | 1,432 | 14.4% | 4,145 | 48.5% | 2,399 | 24.9% | 549 | 5.7% | 310 | 3.4% | |
| MAY14 | 9,155 | 315 | 2.6% | 1,371 | 13.6% | 4,153 | 47.8% | 2,423 | 25.7% | 570 | 6.9% | 323 | 3.4% | |
| JUN14 | 9,216 | 325 | 2.6% | 1,396 | 13.6% | 4,138 | 46.6% | 2,462 | 28.0% | 566 | 6.0% | 329 | 3.2% | |
| JUL14 | 9,252 | 361 | 2.8% | 1,391 | 11.1% | 4,151 | 48.0% | 2,480 | 28.9% | 549 | 6.0% | 320 | 3.1% | |
| AUG14 | 9,294 | 331 | 2.4% | 1,370 | 11.6% | 4,231 | 49.3% | 2,498 | 27.1% | 554 | 6.3% | 310 | 3.3% | |
| SEP14 | 9,322 | 362 | 3.2% | 1,308 | 11.5% | 4,275 | 48.8% | 2,489 | 26.2% | 575 | 6.4% | 313 | 3.8% | |
| OCT14 | 9,406 | 328 | 2.6% | 1,361 | 11.4% | 4,331 | 48.2% | 2,531 | 28.1% | 547 | 5.8% | 308 | 3.9% | |
| NOV14 | 9,378 | 347 | 2.7% | 1,384 | 11.8% | 4,235 | 48.0% | 2,516 | 28.3% | 601 | 6.1% | 295 | 3.2% | |
| DEC14 | 9,236 | 362 | 3.1% | 1,363 | 12.7% | 4,099 | 46.5% | 2,527 | 28.0% | 575 | 6.2% | 310 | 3.4% | |
| JAN15 | 9,147 | 361 | 4.2% | 1,395 | 13.4% | 4,005 | 46.2% | 2,525 | 26.6% | 551 | 6.1% | 310 | 3.6% | |
| FEB15 | 9,115 | 373 | 4.1% | 1,391 | 12.3% | 4,013 | 46.2% | 2,459 | 27.4% | 572 | 6.2% | 307 | 3.6% | |
| MAR15 | 7,255 | 296 | 3.8% | 1,180 | 14.4% | 3,186 | 45.0% | 1,887 | 26.7% | 468 | 6.2% | 238 | 3.8% | |
| APR15 | 8,289 | 325 | 3.3% | 1,373 | 14.2% | 3,593 | 46.1% | 2,207 | 27.4% | 528 | 6.0% | 263 | 3.1% | |
| MAY15 | 8,659 | 337 | 2.9% | 1,403 | 14.0% | 3,936 | 47.2% | 2,185 | 27.4% | 529 | 5.3% | 269 | 3.1% | |
| JUN15 | 9,028 | 417 | 3.6% | 1,466 | 13.4% | 3,998 | 46.5% | 2,291 | 27.5% | 570 | 5.9% | 286 | 3.1% | |
| JUL15 | 9,363 | 480 | 3.8% | 1,514 | 13.4% | 4,101 | 45.4% | 2,379 | 28.0% | 588 | 6.1% | 301 | 3.3% | |
| AUG15 | 9,482 | 485 | 4.2% | 1,530 | 12.7% | 4,070 | 45.3% | 2,507 | 28.6% | 577 | 6.0% | 313 | 3.1% | |
| SEP15 | 9,540 | 493 | 3.6% | 1,531 | 14.4% | 4,071 | 44.8% | 2,531 | 28.0% | 614 | 6.0% | 300 | 3.1% | |
| OCT15 | 9,605 | 537 | 4.5% | 1,463 | 14.1% | 4,165 | 44.9% | 2,551 | 27.8% | 610 | 5.8% | 279 | 2.9% | |
| NOV15 | 9,704 | 515 | 4.5% | 1,544 | 13.9% | 4,183 | 44.3% | 2,584 | 28.5% | 588 | 5.8% | 290 | 3.0% | |
| DEC15 | 9,694 | 481 | 4.0% | 1,558 | 14.1% | 4,189 | 43.4% | 2,545 | 29.0% | 622 | 6.1% | 299 | 3.3% | |
| JAN16 | 9,691 | 481 | 3.9% | 1,548 | 13.7% | 4,220 | 44.6% | 2,520 | 28.0% | 628 | 6.5% | 294 | 3.2% | |
| FEB16 | 9,730 | 490 | 3.8% | 1,558 | 14.4% | 4,242 | 44.0% | 2,514 | 27.7% | 630 | 6.8% | 296 | 3.3% | |
| MAR16 | 9,767 | 531 | 4.8% | 1,595 | 13.5% | 4,238 | 44.8% | 2,552 | 28.0% | 572 | 5.8% | 279 | 3.1% | |
| APR16 | 9,754 | 505 | 4.6% | 1,579 | 13.7% | 4,176 | 43.8% | 2,649 | 28.8% | 554 | 6.0% | 291 | 3.0% | |
| MAY16 | 9,762 | 526 | 4.2% | 1,564 | 13.7% | 4,165 | 43.2% | 2,663 | 30.3% | 548 | 5.7% | 296 | 3.0% | |
| JUN16 | 9,809 | 546 | 4.1% | 1,586 | 12.9% | 4,227 | 43.9% | 2,594 | 29.8% | 560 | 6.2% | 296 | 3.1% | |
| JUL16 | 9,577 | 544 | 3.7% | 1,578 | 12.8% | 4,128 | 45.4% | 2,459 | 28.8% | 570 | 6.2% | 298 | 3.1% | |
| AUG16 | 9,507 | 520 | 3.7% | 1,483 | 12.1% | 4,162 | 45.7% | 2,478 | 29.8% | 581 | 5.7% | 283 | 3.1% | |
| SEP16 | 9,416 | 525 | 4.2% | 1,427 | 13.0% | 3,997 | 43.8% | 2,613 | 30.4% | 555 | 5.3% | 299 | 3.2% | |
| OCT16 | 9,413 | 509 | 4.2% | 1,439 | 13.1% | 4,055 | 43.5% | 2,561 | 30.2% | 554 | 6.1% | 295 | 2.9% | |
| NOV16 | 9,278 | 484 | 4.4% | 1,436 | 12.6% | 3,995 | 44.5% | 2,515 | 29.4% | 564 | 6.1% | 284 | 2.9% | |
| DEC16 | 9,303 | 482 | 4.4% | 1,493 | 13.9% | 3,974 | 44.4% | 2,431 | 27.3% | 634 | 6.8% | 289 | 3.3% | |
| JAN17 | 9,323 | 488 | 4.4% | 1,440 | 13.7% | 3,990 | 45.7% | 2,495 | 26.6% | 593 | 5.9% | 317 | 3.7% | |
| FEB17 | 9,335 | 499 | 4.3% | 1,484 | 13.7% | 4,002 | 45.3% | 2,425 | 27.4% | 616 | 5.8% | 309 | 3.6% | |
| MAR17 | 9,231 | 499 | 4.1% | 1,461 | 13.1% | 3,963 | 44.3% | 2,438 | 29.2% | 572 | 6.0% | 298 | 3.3% | |
| APR17 | 9,208 | 516 | 5.0% | 1,468 | 13.3% | 3,935 | 43.0% | 2,426 | 29.2% | 579 | 6.5% | 284 | 3.0% | |
| MAY17 | 9,280 | 508 | 4.7% | 1,544 | 13.9% | 3,941 | 44.0% | 2,378 | 27.4% | 624 | 7.0% | 285 | 2.9% | |
| JUN17 | 9,378 | 566 | 4.9% | 1,530 | 13.8% | 3,922 | 43.1% | 2,423 | 27.7% | 648 | 7.6% | 289 | 3.0% | |
| JUL17 | 9,368 | 551 | 4.2% | 1,520 | 13.7% | 3,961 | 44.1% | 2,422 | 27.4% | 612 | 7.2% | 302 | 3.4% | |
| AUG17 | 9,368 | 537 | 4.1% | 1,557 | 13.8% | 3,876 | 43.0% | 2,456 | 28.7% | 632 | 6.8% | 310 | 3.6% | |
| SEP17 | 9,344 | 529 | 4.1% | 1,531 | 14.4% | 3,892 | 42.4% | 2,471 | 28.7% | 595 | 6.6% | 326 | 3.7% | |
| OCT17 | 9,419 | 520 | 3.9% | 1,459 | 12.5% | 3,947 | 43.2% | 2,560 | 29.2% | 586 | 6.8% | 347 | 4.3% | |
| NOV17 | 9,262 | 510 | 3.8% | 1,436 | 11.8% | 3,874 | 43.8% | 2,515 | 29.2% | 606 | 7.4% | 321 | 4.0% | |
| DEC17 | 9,280 | 531 | 4.2% | 1,464 | 13.4% | 3,913 | 43.5% | 2,399 | 26.7% | 655 | 8.3% | 318 | 3.9% | |
| JAN18 | 9,269 | 518 | 4.9% | 1,543 | 15.0% | 3,934 | 43.6% | 2,352 | 25.9% | 610 | 7.1% | 312 | 3.6% | |
| FEB18 | 9,344 | 553 | 4.6% | 1,530 | 15.0% | 3,998 | 45.1% | 2,374 | 25.1% | 573 | 6.7% | 316 | 3.5% | |
| MAR18 | 5,695 | 362 | 6.0% | 1,016 | 17.7% | 2,381 | 44.6% | 1,446 | 21.8% | 326 | 5.8% | 164 | 4.1% | |
| APR18 | 8,626 | 449 | 4.6% | 1,380 | 14.0% | 3,644 | 42.1% | 2,317 | 29.0% | 557 | 7.0% | 279 | 3.3% | |
| MAY18 | 9,156 | 471 | 4.1% | 1,378 | 12.5% | 4,005 | 45.8% | 2,448 | 27.7% | 548 | 6.6% | 306 | 3.3% | |
| JUN18 | 9,450 | 496 | 4.0% | 1,463 | 13.1% | 4,030 | 44.5% | 2,572 | 29.1% | 577 | 5.9% | 312 | 3.3% | |
| JUL18 | 9,764 | 527 | 4.2% | 1,560 | 13.5% | 4,221 | 45.1% | 2,530 | 27.6% | 587 | 6.1% | 339 | 3.5% | |
| AUG18 | 10,106 | 591 | 4.3% | 1,715 | 13.7% | 4,347 | 45.2% | 2,478 | 27.2% | 634 | 5.9% | 341 | 3.6% | |
| SEP18 | 10,362 | 647 | 4.4% | 1,693 | 12.8% | 4,490 | 45.2% | 2,556 | 28.0% | 616 | 6.0% | 360 | 3.6% | |
| OCT18 | 10,358 | 650 | 4.7% | 1,667 | 12.2% | 4,464 | 44.5% | 2,616 | 29.1% | 605 | 6.2% | 356 | 3.2% | |
| NOV18 | 10,263 | 588 | 4.2% | 1,673 | 12.6% | 4,475 | 45.2% | 2,575 | 28.6% | 613 | 6.1% | 339 | 3.3% | |
| DEC18 | 10,175 | 601 | 4.3% | 1,659 | 13.3% | 4,455 | 45.9% | 2,520 | 27.0% | 606 | 6.2% | 334 | 3.3% | |
| JAN19 | 10,116 | 575 | 4.5% | 1,687 | 13.8% | 4,428 | 46.0% | 2,504 | 26.3% | 573 | 5.8% | 349 | 3.6% | |
| FEB19 | 10,081 | 603 | 4.8% | 1,746 | 14.9% | 4,322 | 45.2% | 2,453 | 25.7% | 600 | 5.8% | 357 | 3.6% | |
| MAR19 | 10,039 | 637 | 5.0% | 1,707 | 14.7% | 4,266 | 44.7% | 2,483 | 26.2% | 576 | 5.7% | 370 | 3.7% | |
| APR19 | 10,026 | 613 | 4.6% | 1,643 | 14.9% | 4,340 | 45.8% | 2,523 | 26.0% | 552 | 5.1% | 355 | 3.7% | |
| MAY19 | 9,980 | 611 | 4.7% | 1,631 | 14.5% | 4,310 | 45.2% | 2,542 | 27.1% | 543 | 5.1% | 343 | 3.5% | |
| JUN19 | 10,301 | 631 | 4.8% | 1,742 | 14.9% | 4,475 | 45.4% | 2,537 | 26.5% | 579 | 5.2% | 337 | 3.2% | |
| JUL19 | 10,721 | 676 | 4.8% | 1,815 | 14.7% | 4,619 | 45.2% | 2,655 | 26.6% | 613 | 5.4% | 343 | 3.3% | |
| AUG19 | 10,814 | 658 | 4.7% | 1,784 | 14.0% | 4,754 | 46.2% | 2,625 | 25.5% | 628 | 6.0% | 365 | 3.4% | |
| SEP19 | 10,654 | 663 | 4.6% | 1,713 | 13.7% | 4,560 | 44.6% | 2,729 | 27.5% | 614 | 5.7% | 375 | 3.9% | |
| OCT19 | 10,912 | 653 | 4.6% | 1,671 | 12.0% | 4,659 | 45.0% | 2,910 | 28.9% | 635 | 5.6% | 384 | 3.9% | |
| NOV19 | 10,749 | 615 | 4.3% | 1,678 | 13.4% | 4,557 | 44.7% | 2,875 | 28.2% | 643 | 5.6% | 381 | 3.9% | |
| DEC19 | 10,759 | 661 | 4.8% | 1,741 | 13.6% | 4,469 | 44.7% | 2,871 | 27.7% | 651 | 5.6% | 366 | 3.6% | |
| JAN20 | 10,613 | 697 | 5.2% | 1,680 | 13.2% | 4,468 | 45.6% | 2,760 | 26.9% | 659 | 5.8% | 349 | 3.4% | |
| FEB20 | 10,538 | 707 | 4.8% | 1,668 | 15.1% | 4,467 | 45.4% | 2,737 | 25.9% | 622 | 5.6% | 337 | 3.3% | |
| MAR20 | 10,385 | 640 | 4.9% | 1,570 | 13.2% | 4,477 | 46.1% | 2,732 | 27.1% | 618 | 5.5% | 348 | 3.2% | |
| APR20 | 10,487 | 619 | 4.4% | 1,532 | 13.0% | 4,451 | 46.1% | 2,858 | 27.5% | 658 | 5.8% | 369 | 3.2% | |
| MAY20 | 10,405 | 610 | 4.3% | 1,442 | 12.3% | 4,433 | 45.0% | 2,882 | 29.1% | 644 | 5.6% | 394 | 3.8% | |
| JUN20 | 10,320 | 606 | 4.1% | 1,450 | 11.9% | 4,334 | 44.7% | 2,868 | 29.6% | 677 | 6.0% | 385 | 3.6% | |
| JUL20 | 10,272 | 602 | 4.4% | 1,410 | 11.1% | 4,269 | 43.9% | 2,908 | 30.2% | 683 | 6.4% | 400 | 4.0% | |
| AUG20 | 10,170 | 532 | 4.0% | 1,448 | 12.0% | 4,223 | 43.9% | 2,899 | 29.7% | 682 | 6.3% | 386 | 4.1% | |
| SEP20 | 9,938 | 516 | 4.3% | 1,408 | 11.9% | 4,087 | 43.4% | 2,851 | 29.3% | 696 | 6.8% | 380 | 4.2% | |
| OCT20 | 9,999 | 536 | 4.4% | 1,494 | 13.7% | 4,066 | 41.9% | 2,839 | 29.1% | 692 | 6.9% | 372 | 4.1% | |
| NOV20 | 9,904 | 600 | 4.8% | 1,469 | 13.8% | 4,004 | 41.1% | 2,801 | 29.6% | 675 | 6.9% | 355 | 3.9% | |
| DEC20 | 9,783 | 587 | 4.8% | 1,411 | 13.0% | 4,043 | 42.9% | 2,717 | 28.5% | 670 | 6.8% | 355 | 4.0% | |
| JAN21 | 9,579 | 596 | 5.1% | 1,463 | 13.5% | 3,903 | 43.1% | 2,636 | 27.7% | 639 | 6.3% | 342 | 4.2% | |
| FEB21 | 7,753 | 501 | 5.5% | 1,201 | 15.4% | 3,063 | 41.4% | 2,159 | 26.9% | 554 | 6.8% | 275 | 4.1% | |
| Values at each month are based on the average of at least two pre-dialysis measurements obtained within the prior 3 months; restricted to patients on dialysis 90+ days |
| Facility sample transitioned from DOPPS 4 to 5 in Jan-Apr 2012 (see "Study Sample and Methods"). |
| Facility sample transitioned from DOPPS 5 to 6 in Mar-Jul 2015 (see "Study Sample and Methods"). |
| Facility sample transitioned from DOPPS 6 to 7 in Feb-May 2018 (see "Study Sample and Methods"). |
| Source: US-DOPPS Practice Monitor, May 2021; http://www.dopps.org/DPM |